IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
IASLC Atlas of ALK and ROS1 Testing in Lung Cancer
September 21, 2017 | Online


These live webinars are intended to help pathologists, scientists and physicians better understand the background, protocol and interpretation of results of ALK and ROS1 testing for NASCLC patients. The primary objectives of this webinar are to:

  • Understand the use of FISH and IHC to detect ALK and ROS1 in non-small cell lung cancer.
  • Give clinicians guidance and interpretation of test results.
  • Optimize treatment of ALK and ROS1 Positive Lung Cancers by identifying patients most likely to benefit from ALK and ROS1 inhibitor therapy.

What you should expect to learn

  • Introduce clinicians to the reference Atlas of Alk and ROS1 testing
  • Provide clinicians and scientists with a clear understanding of the background, testing protocols and interpretation of results of ALK and RPOS1 testing.
  • Identify and review the use of FISH (Fluoroescence In Situ Hybridization) and IHC (ImmunoHistoChemistry) to detect ALK.

Prof. Keith Kerr, 
Department of Pathology
Aberdeen University Medical School
Aberdeen Royal Infirmary
Aberdeen, UK